Author Archives: impact ethics
Monopolies on New Medicines & Trade with the U.S.
Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.
From Bench to Bedside via… The Island of Dr Moreau?
Jason Scott Robert suggests that the creation of part-human animals in stem cell biology may generate scientific confusion.
Join the Debate on Human Genome Editing!
Yeyang Su invites Impact Ethics readers to mark their calendars for the second International Summit on Human Genome Editing.
Reimbursing Surrogates & Donors
Françoise Baylis supports the proposed new regulations for reimbursement related to assisted human reproduction.
Thicker than Water: Slow Movement on Blood Policy
Landon J. Getz provides an update on Canadian Blood Services’ progress in updating outmoded policies on gay blood donation.
Impact Ethics 